Draw
|
Currency :
Structure Search
AG0037J6
3778-73-2 | 3-(2-Chloroethyl)-2-(2-chloroethylamino)tetrahydro-2H-1,3,2-oxaazaphosphorin 2-oxide
AG0037J6
SDS
COA
Add to Cart
Request For Quotation
- mg
- g
- kg
- ml
- L
无数据
无数据
- mg
- g
- kg
- ml
- L
无数据
| CAS Number | 3778-73-2 |
| Catalog Number | AG0037J6(AGN-PC-0REQN6) |
| Chemical Name | 3-(2-Chloroethyl)-2-(2-chloroethylamino)tetrahydro-2H-1,3,2-oxaazaphosphorin 2-oxide |
| EC Number | 223-237-3 |
| IUPAC Name | N,3-bis(2-chloroethyl)-2-oxo-1,3,2λ5-oxazaphosphinan-2-amine |
| InChI | InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12) |
| InChI Key | HOMGKSMUEGBAAB-UHFFFAOYSA-N |
| MDL Number | MFCD00057374 |
| Molecular Formula | C7H15Cl2N2O2P |
| Molecular Weight | 261.0860 |
| SMILES | ClCCN1P(OCCC1)(NCCCl)=O |
| UNII | UM20QQM95Y |
| Synonyms | Asta Z 4942,
Holoxan,
Ifosfamide,
Iphosphamide,
Iso Endoxan,
Iso-Endoxan,
Isofosfamide,
Isophosphamide,
NSC 109,724,
NSC 109724,
NSC-109,724,
NSC-109724,
NSC109,724,
NSC109724,
ifosfamide,
Isophosphamide,
3778-73-2,
Iphosphamide,
Isofosfamide,
Ifosfamid,
Mitoxana,
Iphosphamid,
Isoendoxan,
Naxamide,
Ifex,
I-Phosphamide,
Holoxan,
Cyfos,
Ifsofamide,
Holoxan 1000,
ASTA Z 4942,
Ifosfamida,
Ifosfamidum,
Ifosphamide,
MJF 9325,
isosfamide,
NCI-C01638,
MJF-9325,
Ifosfamide Sterile,
Ifosfamidum [INN-Latin],
Ifosfamida [INN-Spanish],
NSC 109724,
NSC-109724,
A 4942,
Z 4942,
Z-4942,
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide,
UNII-UM20QQM95Y,
Z4942,
NSC109724,
CCRIS 352,
N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide,
HSDB 7023,
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide,
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide,
EINECS 223-237-3,
BRN 0611835,
dexifosfamide,
C7H15Cl2N2O2P,
UM20QQM95Y,
CHEBI:5864,
HOMGKSMUEGBAAB-UHFFFAOYSA-N,
2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd,
N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide,
N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide,
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide,
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide,
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide,
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide,
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German],
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide,
NCGC00016639-01,
CAS-3778-73-2,
DSSTox_CID_760,
Iso-Endoxan,
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide,
DSSTox_RID_75775,
DSSTox_GSID_20760,
(D,L)-Ifosfamide,
Q-101874,
(+-)-Ifosphamide,
(+-)-Ifosfamid,
(R,S)-Ifosphamide,
Iphosphamid(e),
N,3-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine,
3-(2-chloroethyl)-2-((2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide,
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide,
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide,
Ifosfamide [USAN:INN:BAN:JAN],
SR-05000002022,
IFEX (TN),
NPFAPI-04,
Ifosfamide (JAN/USP/INN),
Mitoxana;Ifex,
N,3-bis(2-chloroethyl)-2-oxo-1,3,2?^{5}-oxazaphosphinan-2-amine,
Ifosfamid A,
(R)-Ifosfamide,
(S)-Ifosfamide,
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorineoxide,
Isophosphamide,(S),
MFCD00057374,
Ifosfamide [USAN:USP:INN:BAN:JAN],
NSC-109,724,
Ifosfamide, >=98%,
AC1L1GHW,
Prestwick0_000833,
Prestwick1_000833,
Prestwick2_000833,
Prestwick3_000833,
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid,
SCHEMBL4885,
(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide,
(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide,
CHEMBL1024,
BSPBio_000785,
KSC948G4P,
MLS002154021,
Ifex (TN) (Bristol Meyers),
SPBio_002706,
BPBio1_000865,
GTPL7201,
DTXSID7020760,
CTK8E8347,
KS-00000YBW,
BDBM189358,
HMS1570H07,
HMS2090M12,
HMS2093N07,
HMS2097H07,
HMS2232O10,
HMS3374B08,
HMS3654B15,
HMS3714H07,
Pharmakon1600-01505480,
{3-(2-Chloroethyl)-2-[(2-,
BCP06596,
WLN: T6NPOTJ AM2G BO B2G,
Tox21_110539,
Tox21_201815,
Tox21_302775,
BBL028071,
CI0037,
NSC759154,
s1302,
STL058690,
AKOS005711213,
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide,
Tox21_110539_1,
AB02316,
AC-2113,
AN-6958,
API0002976,
CCG-213464,
CS-1424,
DB01181,
MCULE-1480299331,
NSC-759154,
2H-1,3,2-Oxazaphosphorin-2-amine, tetrahydro-N,3-bis(2-chloroethyl)-, 2-oxide, (+-)-,
N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine,
Ifosfamide, analytical reference material,
NCGC00179435-01,
NCGC00179435-02,
NCGC00179435-03,
NCGC00179435-06,
NCGC00179435-07,
NCGC00256413-01,
NCGC00259364-01,
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI),
AS-10978,
CC-29468,
HY-17419,
LS-99799,
NCI60_000233,
SC-12120,
SMR001233348,
TA-01010,
ACM1189701130,
SBI-0206804.P001,
AB0008491,
AB2000039,
AB00513932,
AK00287982,
FT-0603650,
SW197177-4,
C07047,
D00343,
J10093,
M-1494,
33899-EP2275420A1,
33899-EP2295055A2,
33899-EP2295416A2,
33899-EP2298748A2,
33899-EP2298764A1,
33899-EP2298765A1,
33899-EP2305642A2,
33899-EP2311453A1,
AB00513932-06,
AB00513932-07,
AB00513932-08,
AB00513932_09,
AB00513932_10,
778I732,
C-16296,
I06-0494,
SR-05000002022-1,
SR-05000002022-3,
SR-05000002022-5,
BRD-A67097164-001-11-2,
Ifosfamide, British Pharmacopoeia (BP) Reference Standard,
Ifosfamide, European Pharmacopoeia (EP) Reference Standard,
UNII-UM20QQM95Y component HOMGKSMUEGBAAB-AWEZNQCLSA-N,
Ifosfamide, United States Pharmacopeia (USP) Reference Standard,
2,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxy-,
2,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd,
2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxy-,
N,3-bis(2-chloroethyl)-2-oxo-1,3,2$l;{5}-oxazaphosphinan-2-amine,
(2S)-3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2|E5-oxazaphosphinan-2-one,
{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,} 2-oxazaphosphorine oxide,
1,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide,
2H-1,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide,
2H-1,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide,
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide,
3-(2-Chloroethyl)-2-(2-chloroethylamino)tetrahydro-2H-1,3,2-oxaazaphosphorin 2-oxide,
3-(2-Chloroethyl)-2-(2-chloroethylamino)tetrahydro-2H-1,3,2-oxazaphosphorin-2-one,
3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2$l;{5}-oxazaphosphinan-2-one,
3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2lambda5-oxazaphosphinan-2-one,
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,2-oxazaphosphorine oxide,
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,2-oxazaphosphorineoxide,
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,2-oxazaphosphorine 2-oxide,
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide,
N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphinan-2-amine 2-oxide #,
ifomide,
ifosfomide,
Iso Endoxan,
Ifex/Mesnex Kit,
Ifosfamide-d4,
Ifosfamide/Mesna Kit,
Mitoxana (TN),
Ifosfamide/Isophosphamide,
D02TLO,
Mitoxana, Ifex, Ifosfamide,
3,} 2-oxazaphosphorine oxide,
Ifosfamide, 98% - 1G 1g,
CID3690,
Ifosfamide [USAN:BAN:INN:JAN],
DRG-0207,
C7-H15-Cl2-N2-O2-P,
LS-102,
CS-O-11667,
NSC109,724,
NSC 109,724,
N,3-bis(2-chloroethyl)-2-oxo-1,3,2,
A2097,
D007069,
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide,
2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd,
2H-1,3,2-Oxazafosforin-2-amina, N,3-bis(2-cloroetil)tetrahidro-, 2-oxido,
N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine-2-oxide,
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide,
3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2h-1,3,2-oxazaphosphorin-2-oxide,
1189701-13-0,
84711-20-6,
|
| Complexity | 218 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 260.025g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 14 |
| Hydrogen Bond Acceptor Count | 4 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 261.083g/mol |
| Monoisotopic Mass | 260.025g/mol |
| Rotatable Bond Count | 5 |
| Topological Polar Surface Area | 41.6A^2 |
| Undefined Atom Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 0.9 |
GHS Hazard and Precautionary Statements
| Symbol: |   |
| Hazard Class | 6.1 |
| Hazard statements | H301-H319-H340-H350-H360 |
| Packing Group | Ⅲ |
| Precautionary statements | P201-P280-P305+P351+P338-P308+P313 |
| UN Code | UN 2811 |
Certificate of Analysis
Lot Number
Related Research Chemicals
CERTIFICATE OF ANALYSIS
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
Analysis Data:
| Test: | Result: |
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited